289 related articles for article (PubMed ID: 23466695)
1. A novel experimental model of cervical spondylotic myelopathy (CSM) to facilitate translational research.
Karadimas SK; Moon ES; Yu WR; Satkunendrarajah K; Kallitsis JK; Gatzounis G; Fehlings MG
Neurobiol Dis; 2013 Jun; 54():43-58. PubMed ID: 23466695
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a novel rat model of cervical spondylotic myelopathy: the impact of chronic cord compression on clinical, neuroanatomical, and neurophysiological outcomes.
Lee J; Satkunendrarajah K; Fehlings MG
J Neurotrauma; 2012 Mar; 29(5):1012-27. PubMed ID: 21561323
[TBL] [Abstract][Full Text] [Related]
3. Cervical spondylotic myelopathy: the clinical phenomenon and the current pathobiology of an increasingly prevalent and devastating disorder.
Kalsi-Ryan S; Karadimas SK; Fehlings MG
Neuroscientist; 2013 Aug; 19(4):409-21. PubMed ID: 23204243
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical profile of NF-κB/p50, NF-κB/p65, MMP-9, MMP-2, and u-PA in experimental cervical spondylotic myelopathy.
Karadimas SK; Klironomos G; Papachristou DJ; Papanikolaou S; Papadaki E; Gatzounis G
Spine (Phila Pa 1976); 2013 Jan; 38(1):4-10. PubMed ID: 22673181
[TBL] [Abstract][Full Text] [Related]
5. Riluzole attenuates neuropathic pain and enhances functional recovery in a rodent model of cervical spondylotic myelopathy.
Moon ES; Karadimas SK; Yu WR; Austin JW; Fehlings MG
Neurobiol Dis; 2014 Feb; 62():394-406. PubMed ID: 24184328
[TBL] [Abstract][Full Text] [Related]
6. Human neuropathological and animal model evidence supporting a role for Fas-mediated apoptosis and inflammation in cervical spondylotic myelopathy.
Yu WR; Liu T; Kiehl TR; Fehlings MG
Brain; 2011 May; 134(Pt 5):1277-92. PubMed ID: 21490053
[TBL] [Abstract][Full Text] [Related]
7. Laminectomy and posterior cervical plating for multilevel cervical spondylotic myelopathy and ossification of the posterior longitudinal ligament: effects on cervical alignment, spinal cord compression, and neurological outcome.
Houten JK; Cooper PR
Neurosurgery; 2003 May; 52(5):1081-7; discussion 1087-8. PubMed ID: 12699550
[TBL] [Abstract][Full Text] [Related]
8. Cilostazol, a selective Type III phosphodiesterase inhibitor: prevention of cervical myelopathy in a rat chronic compression model.
Yamamoto S; Kurokawa R; Kim P
J Neurosurg Spine; 2014 Jan; 20(1):93-101. PubMed ID: 24206033
[TBL] [Abstract][Full Text] [Related]
9. New experimental rabbit animal model for cervical spondylotic myelopathy.
Klironomos G; Karadimas S; Mavrakis A; Mirilas P; Savvas I; Papadaki E; Papachristou DJ; Gatzounis G
Spinal Cord; 2011 Nov; 49(11):1097-102. PubMed ID: 21788956
[TBL] [Abstract][Full Text] [Related]
10. Preoperative evaluation of the cervical spondylotic myelopathy with flexion-extension magnetic resonance imaging: about a prospective study of fifty patients.
Zhang L; Zeitoun D; Rangel A; Lazennec JY; Catonné Y; Pascal-Moussellard H
Spine (Phila Pa 1976); 2011 Aug; 36(17):E1134-9. PubMed ID: 21785299
[TBL] [Abstract][Full Text] [Related]
11. Limaprost alfadex, a prostaglandin E1 derivative, prevents deterioration of forced exercise capability in rats with chronic compression of the spinal cord.
Kurokawa R; Nagayama E; Murata H; Kim P
Spine (Phila Pa 1976); 2011 May; 36(11):865-9. PubMed ID: 21192291
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of spinal cord dysfunction and cell death in the spinal hyperostotic mouse: implications for the pathophysiology of human cervical spondylotic myelopathy.
Yu WR; Baptiste DC; Liu T; Odrobina E; Stanisz GJ; Fehlings MG
Neurobiol Dis; 2009 Feb; 33(2):149-63. PubMed ID: 19006686
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology and natural history of cervical spondylotic myelopathy.
Karadimas SK; Erwin WM; Ely CG; Dettori JR; Fehlings MG
Spine (Phila Pa 1976); 2013 Oct; 38(22 Suppl 1):S21-36. PubMed ID: 23963004
[TBL] [Abstract][Full Text] [Related]
14. Riluzole blocks perioperative ischemia-reperfusion injury and enhances postdecompression outcomes in cervical spondylotic myelopathy.
Karadimas SK; Laliberte AM; Tetreault L; Chung YS; Arnold P; Foltz WD; Fehlings MG
Sci Transl Med; 2015 Dec; 7(316):316ra194. PubMed ID: 26631633
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study of cervical spondylotic myelopathy--spinal cord blood flow in cervical canal stenosis (author's transl)].
Nakamura K; Machida H; Tanaka H; Kobayashi M; Hoshino Y; Iizuka T; Kurokawa T
Nihon Seikeigeka Gakkai Zasshi; 1981 Aug; 55(8):747-54. PubMed ID: 7310208
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance T2 image signal intensity ratio and clinical manifestation predict prognosis after surgical intervention for cervical spondylotic myelopathy.
Zhang YZ; Shen Y; Wang LF; Ding WY; Xu JX; He J
Spine (Phila Pa 1976); 2010 May; 35(10):E396-9. PubMed ID: 20393392
[TBL] [Abstract][Full Text] [Related]
17. Cervical spondylotic myelopathy.
Tracy JA; Bartleson JD
Neurologist; 2010 May; 16(3):176-87. PubMed ID: 20445427
[TBL] [Abstract][Full Text] [Related]
18. Postdecompressive spinal cord blood flow increments in a cervical chronic myelopathy model in rats.
Yamamoto S; Kurokawa R; Kim P
J Neurosurg Spine; 2021 Jun; 35(2):202-210. PubMed ID: 34144516
[TBL] [Abstract][Full Text] [Related]
19. Zonisamide ameliorates progression of cervical spondylotic myelopathy in a rat model.
Kanbara S; Ohkawara B; Nakashima H; Ohta K; Koshimizu H; Inoue T; Tomita H; Ito M; Masuda A; Ishiguro N; Imagama S; Ohno K
Sci Rep; 2020 Aug; 10(1):13138. PubMed ID: 32753675
[TBL] [Abstract][Full Text] [Related]
20. Cervical Decompression Surgery Normalizes Gait Ground Reaction Forces in Patients With Cervical Spondylotic Myelopathy.
Haddas R; Derman PB
Spine (Phila Pa 1976); 2020 Sep; 45(18):E1134-E1141. PubMed ID: 32341299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
